Chief Says Pfizer Japan Still Wants Local R&D Ties Despite Recent Moves
This article was originally published in PharmAsia News
Executive Summary
Pfizer Japan President Ichiro Umeda said that although his company closed its R&D base in Japan, the firm intends to draw on the nation’s university-based community for innovative work.